Interleukin-6 receptor antagonist therapy to treat SARS-CoV-2 driven inflammatory syndrome in a kidney transplant recipient.
作者信息
Allam Sridhar R, Dao Ann, Madhrira Machaiah M, Antiporta Philip B, Nair Ranjit R, Guiteau Jacfranz J, Reyad Ashraf I
机构信息
Tarrant Nephrology Associates/Premier Physicians Group Health, Fort Worth, Texas, USA.
Medical City Fort Worth Transplant Institute, Fort Worth, Texas, USA.
出版信息
Transpl Infect Dis. 2020 Aug;22(4):e13326. doi: 10.1111/tid.13326. Epub 2020 Jun 5.
Abstract
摘要
相似文献
1
Interleukin-6 receptor antagonist therapy to treat SARS-CoV-2 driven inflammatory syndrome in a kidney transplant recipient.白细胞介素-6受体拮抗剂疗法治疗肾移植受者中由SARS-CoV-2驱动的炎症综合征。
Transpl Infect Dis. 2020 Aug;22(4):e13326. doi: 10.1111/tid.13326. Epub 2020 Jun 5.
2
Tocilizumab, an anti-IL-6 receptor antibody, to treat COVID-19-related respiratory failure: a case report.托珠单抗，一种抗白细胞介素-6受体抗体，用于治疗新型冠状病毒肺炎相关呼吸衰竭：一例病例报告。
Ann Oncol. 2020 Jul;31(7):961-964. doi: 10.1016/j.annonc.2020.03.300. Epub 2020 Apr 2.
3
Cytokine Storm Drugs Move from CAR T to COVID-19.细胞因子风暴药物从 CAR-T 疗法转移到 COVID-19。
Cancer Discov. 2020 Jul;10(7):OF8. doi: 10.1158/2159-8290.CD-ND2020-008. Epub 2020 May 5.
4
Kidney Transplantation and COVID-19.肾移植与新型冠状病毒肺炎
R I Med J (2013). 2020 Sep 4;103(8):34-37.
5
Interleukin 6 levels after tocilizumab administration in transplant recipients with COVID-19.托珠单抗治疗新型冠状病毒肺炎移植受者后的白细胞介素6水平
Kidney Int. 2020 Oct;98(4):1054. doi: 10.1016/j.kint.2020.06.025. Epub 2020 Jul 8.
6
Tocilizumab for Hemophagocytic Syndrome in a Kidney Transplant Recipient With COVID-19.托珠单抗用于一名合并 COVID-19 的肾移植受者的噬血细胞综合征
Ann Intern Med. 2020 Sep 15;173(6):501-503. doi: 10.7326/L20-0419. Epub 2020 May 18.
7
Early tocilizumab treatment could improve survival among COVID-19 patients.早期使用托珠单抗治疗可提高新冠病毒疾病患者的生存率。
Clin Exp Rheumatol. 2020 May-Jun;38(3):578. Epub 2020 May 27.
8
Treat 2019 novel coronavirus (COVID-19) with IL-6 inhibitor: Are we already that far?用白细胞介素-6抑制剂治疗2019新型冠状病毒（COVID-19）：我们已经进展到那一步了吗？
Drug Discov Ther. 2020;14(2):100-102. doi: 10.5582/ddt.2020.03006.
9
Lack of tocilizumab effect on mortality in COVID19 patients.托珠单抗对 COVID-19 患者死亡率无影响。
Sci Rep. 2020 Oct 13;10(1):17100. doi: 10.1038/s41598-020-74328-x.
10
Tocilizumab in the treatment of a critical COVID-19 patient: a case report.托珠单抗治疗危重症 COVID-19 患者 1 例报告。
Eur Rev Med Pharmacol Sci. 2020 May;24(10):5783-5787. doi: 10.26355/eurrev_202005_21372.
引用本文的文献
1
Recent advances in passive immunotherapies for COVID-19: The Evidence-Based approaches and clinical trials.新型冠状病毒肺炎被动免疫治疗的最新进展：基于证据的方法和临床试验。
Int Immunopharmacol. 2022 Aug;109:108786. doi: 10.1016/j.intimp.2022.108786. Epub 2022 Apr 21.
2
Coronavirus-19 infection in kidney transplant recipients: A comprehensive review.肾移植受者中的新型冠状病毒-19感染：一项综述
Indian J Urol. 2022 Apr-Jun;38(2):110-114. doi: 10.4103/iju.iju_430_21. Epub 2022 Apr 1.
3
Early Fall in C-Reactive Protein (CRP) Level Predicts Response to Tocilizumab in Rapidly Progressing COVID-19: Experience in a Single-Arm Pakistani Center.C反应蛋白（CRP）水平早期下降预示着托珠单抗对快速进展型COVID-19的疗效：来自巴基斯坦单中心的经验
Cureus. 2021 Nov 30;13(11):e20031. doi: 10.7759/cureus.20031. eCollection 2021 Nov.
4
SARS-CoV-2 in Solid Organ Transplant Recipients: A Structured Review of 2020.SARS-CoV-2 在实体器官移植受者中的研究进展：2020 年的系统综述
Transplant Proc. 2021 Oct;53(8):2421-2434. doi: 10.1016/j.transproceed.2021.08.019. Epub 2021 Aug 16.
5
The Management of Immunosuppression in Kidney Transplant Recipients with COVID-19 Disease: An Update and Systematic Review of the Literature.COVID-19疾病肾移植受者的免疫抑制管理：文献综述与最新进展
Medicina (Kaunas). 2021 Apr 30;57(5):435. doi: 10.3390/medicina57050435.
6
Effect of immunosuppression maintenance in solid organ transplant recipients with COVID-19: Systematic review and meta-analysis.COVID-19 患者中实体器官移植受者免疫抑制维持的效果：系统评价和荟萃分析。
Transpl Infect Dis. 2021 Aug;23(4):e13595. doi: 10.1111/tid.13595. Epub 2021 Mar 18.
7
COVID-19 in SOT versus non-SOT.实体器官移植受者与非实体器官移植受者中的新型冠状病毒肺炎
Am J Transplant. 2021 Jun;21(6):2304-2305. doi: 10.1111/ajt.16481. Epub 2021 Feb 8.
8
COVID-19 in solid organ transplant recipients: A systematic review and meta-analysis of current literature.实体器官移植受者中的新型冠状病毒肺炎：当前文献的系统评价与荟萃分析
Transplant Rev (Orlando). 2021 Jan;35(1):100588. doi: 10.1016/j.trre.2020.100588. Epub 2020 Nov 14.
9
Management of Canadian Pediatric Patients With Glomerular Diseases During the COVID-19 Pandemic: Recommendations From the Canadian Association of Pediatric Nephrologists COVID-19 Rapid Response Team.COVID-19大流行期间加拿大儿童肾小球疾病患者的管理：加拿大儿科肾脏病学家协会COVID-19快速反应小组的建议
Can J Kidney Health Dis. 2020 Nov 13;7:2054358120970713. doi: 10.1177/2054358120970713. eCollection 2020.
10
Management of Pediatric Kidney Transplant Patients During the COVID-19 Pandemic: Guidance From the Canadian Society of Transplantation Pediatric Group.2019冠状病毒病大流行期间小儿肾移植患者的管理：加拿大移植学会儿科组的指南
Can J Kidney Health Dis. 2020 Nov 13;7:2054358120967845. doi: 10.1177/2054358120967845. eCollection 2020.
Zotero 插件